MJW-19396-37485
3 vaccinations
4 coded responses
38 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 230 / VA
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
TMS-16340-73034
Child or adolescent in my care · Female · 2022-06-28
BHP-18231-40642
Child or adolescent in my care · Male · 2022-06-29
Timeline
-
2021-03-11
Registered in v-safe
-
2021-03-11
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-11
-
2021-03-12
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
- 2021-03-13
-
2021-03-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
-
2021-03-25
Survey response — day 14, dose 1MedDRA: Fatigue, Nausea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Extreme exhaustion and nauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
-
2021-04-08
Survey response — day 28, single doseMedDRA: Nasopharyngitis — Feeling: GoodFree text: ColdMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-15
- 2021-04-22
- 2021-06-10
- 2021-09-09
-
2021-10-25
Dose 2 — Moderna
- 2021-10-31
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-12-01
-
2021-12-06
Survey response — day 42, dose 2MedDRA: Nasopharyngitis, SARS-CoV-2 test — Feeling: FairFree text: Bad cold- awaiting Covid resultsMedDRA releases: 2024-11 · check-in free text available
- 2022-01-24
- 2022-04-25
-
2022-09-13
Dose 3 — Moderna
- 2022-09-13
-
2022-09-14
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-16
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-20
- 2022-09-27
- 2022-10-04
-
2022-10-11
Survey response — day 28, dose 3MedDRA: Respiratory syncytial virus infection — Feeling: Fair · Be unable to do your normal daily activitiesFree text: RSVMedDRA releases: 2024-11 · check-in free text available
- 2022-10-18
- 2022-10-25
- 2022-12-13
- 2023-03-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-25 | Moderna | No |
| 3 | 2022-09-13 | Moderna | No |
Free text
Release 6 — day 14, dose 1
Symptoms: Extreme exhaustion and nausea
Release 7 — day 28, single dose
Symptoms: Cold
Release 10 — day 42, dose 2
Symptoms: Bad cold- awaiting Covid results
Release 12 — day 28, dose 3
Symptoms: RSV
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | SARS-CoV-2 test | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release